sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Tirasemtiv

Tirasemtiv

CAS No.:
1005491-05-3
Catalog Number:
AG003AUE
Molecular Formula:
C12H14N4O
Molecular Weight:
230.2658
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
96%
In Stock USA
United States
$475
- +
1g
96%
In Stock USA
United States
$1150
- +
5g
96%
In Stock USA
United States
$3500
- +
Product Description
Catalog Number:
AG003AUE
Chemical Name:
Tirasemtiv
CAS Number:
1005491-05-3
Molecular Formula:
C12H14N4O
Molecular Weight:
230.2658
MDL Number:
MFCD28023588
IUPAC Name:
5-ethynyl-3-pentan-3-yl-1H-imidazo[4,5-b]pyrazin-2-one
InChI:
InChI=1S/C12H14N4O/c1-4-8-7-13-10-11(14-8)16(12(17)15-10)9(5-2)6-3/h1,7,9H,5-6H2,2-3H3,(H,13,15,17)
InChI Key:
RSQGZEAXODVTOL-UHFFFAOYSA-N
SMILES:
CCC(n1c(=O)[nH]c2c1nc(C#C)cn2)CC
UNII:
G8WSM7R635
Properties
Complexity:
344  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
230.117g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
230.271g/mol
Monoisotopic Mass:
230.117g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
58.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.4  
Literature
Title Journal
Tirasemtiv amplifies skeletal muscle response to nerve activation in humans. Muscle & nerve 20141201
Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease. Vascular medicine (London, England) 20140801
A study to evaluate safety and tolerability of repeated doses of tirasemtiv in patients with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 20131201
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20120901
Amyotrophic lateral sclerosis: drug therapy from the bench to the bedside. Seminars in neurology 20120701
Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases. Nature medicine 20120301
Properties